ESC 365 - New echocardiographic approaches to differentiate cardiac amyloidosis and Fabry disease: the right heart and mitral valve thickness

ESC Professional Premium Access

New echocardiographic approaches to differentiate cardiac amyloidosis and Fabry disease: the right heart and mitral valve thickness

Session: Risk stratification of cardiomyopathies with echocardiography

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Speaker: Doctor I. Mattig (Berlin, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Isabel Mattig

Charité - University Medicine Berlin, Berlin (Germany)

1 presentation

0 follower

7 more presentations in this session

Could echocardiographic left atrial characterization have additive value for detecting risks of atrial arrhythmias and stroke in patients with hypertrophic cardiomyopathy?

Speaker: Mr A. Al wazzan (Rennes, FR)

A novel echocardiographic risk score predicts prognosis in AL-amyloidosis

Speaker: Doctor P. Geenty (Westmead, AU)

Echocardiographic assessment of left ventricular radial strain to differentiate cardiac amyloidosis from Fabry disease

Speaker: Mr T. Steudel (Berlin, DE)

Reduced 3D-left atrium ejection fraction predicts development of atrial fibrillation in patients with hypertrophic cardiomyopathy

Speaker: Doctor A. Amador (Porto, PT)

Quantification of systolic anterior motion of the mitral valve to predict left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy

Speaker: Doctor D. Zach (Graz, AT)

Access the full session

Risk stratification of cardiomyopathies with echocardiography

Speakers: Doctor I. Mattig, Mr A. Al wazzan, Doctor P. Geenty, Mr T. Steudel, Doctor A. Amador...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources